EV20-Sap, a novel anti-HER-3 antibody-drug conjugate, displays promising antitumor activity in melanoma.
Capone E, Giansanti F, Ponziani S, Lamolinara A, Iezzi M, Cimini A, Angelucci F, Sorda R, Laurenzi V, Natali PG, Ippoliti R, Iacobelli S, Sala G.
Capone E, et al.
Oncotarget. 2017 Sep 8;8(56):95412-95424. doi: 10.18632/oncotarget.20728. eCollection 2017 Nov 10.
Oncotarget. 2017.
PMID: 29221137
Free PMC article.